ANUH PHARMA Q2 : STANDALONE NET PROFIT UP 47.3% AT 11.21 CR (YOY), DOWN 1.9% (QOQ). MIX (ON 1ST LOOK)

Revenue down 0.3% at 185.24 Cr (YOY), down 4.4% (QOQ). Ebitda up 36.5% at 17.55 Cr (YOY); margins 9.47% v 6.92% (YOY), 9.99% (QOQ). H1 net profit up 42.3% at 22.64 Cr on revenue of 379.05 Cr (YOY).

Anuh Pharma Limited

Open attachment

← Back to feed